Oral Posiphen® Treatment Lowers Aß42 in Mouse Brain

Poster, July 2006. ICAD, More >>>>>

Post navigation

Search for:

Recent Posts

Targeting Alzheimer’s and Other Neurodegenerative Diseases via a Novel Mechanism of Action
Targeting Alzheimer’s with Novel Therapuetics
Healthcare Businesswomen’s Association: Women in Science – Winter 2011
Maria Maccecchini to Receive 2011 Iris Newmann Award – November 16, 2011
Maria Maccecchini, President and CEO of QR Pharma, Inc. to Serve on Panel with Nobel Laureate, Phillip Sharp at Chemical Heritage Foundation Event

Scroll to Top